Navigation Links
Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
Date:7/14/2011

ROCKVILLE, Md., July 14, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: "Compositions to Effect Neuronal Growth."  The patents cover three new compounds and include both structure and method claims for inducing neurogenesis and the growth of new neurons, both in-vitro and in-vivo.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

Neuralstem's first neurogenic patented compound is currently in a Phase I FDA-approved safety trial in major depressive disorder. The Phase Ia trial, which is in healthy volunteers, is scheduled to be completed in August. The Phase Ib safety trial in depressed patients is expected to commence this fall.

"These patents cover additional new chemical entities from our neurogenic program and broaden our potential clinical development pipeline," said Karl Johe, Ph.D., Neuralstem Chairman and Chief Scientific Officer.  "Our proprietary neural stem cell technology allows for a unique window into the process of neurogenesis. Through this, we've discovered novel chemical compounds that are truly neurogenic. We believe that our portfolio of neurogenic compounds will be at the forefront of novel treatments for psychiatric and cognitive diseases that focus on neural regeneration, not just brain chemistry."

"This is also an important validation of our screening platform," said Richard Garr, Neuralstem President & CEO. "We are not only able to identify neurogenic and neuroprotective compounds by screening against our cells, but we can also identify novel, patentable compounds, across a diverse chemical library.   As the patents run out across the industry on many CNS drugs, we believe Neuralstem is well-positioned to provide value to our future development partners."  

About
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstem Updates NSI-189 Major Depression Trial
2. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
3. Neuralstem Updates ALS Clinical Trial Progress
4. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
5. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
6. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
7. Neuralstems ALS Trial on Clinical Hold
8. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
9. Neuralstem Announces Issuance of Core Technology Patent in Europe
10. Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox
11. Access Pharmaceuticals Announces Restructuring of Outstanding Senior Convertible Note
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Calif., Sept. 18, 2014  PRO-DEX, INC. (NasdaqCM: PDEX) ... quarter and full-year ended June 30, 2014. ... three months ended June 30, 2014 increased $492,000, or ... three months ended June 30, 2013, due primarily to ... repair revenues from the Company,s largest customer, partially offset ...
(Date:9/18/2014)... Research and Markets has announced ... Investment Report, 2014-2016" report to their offering. ... in percutaneous coronary intervention (PCI), serves not only as ... device for pre-/post-stent dilatations. Therefore, the development of PTCA ... As national economy develops and people,s living ...
(Date:9/18/2014)... 2014  Iliad Neurosciences, Inc., a company focused on ... Autism Spectrum Disorders (ASD) announced today that it has ... Foundation for The State University of New York. ... biomarker to identify an abnormality in folate transport to ... is expected to be available for research use by ...
Breaking Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 2Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 4Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 5Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 6Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 7Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 8Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 9Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 10Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 11Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 12Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 13China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3
... Inc. (Nasdaq: NBIX ) announced today that the Company ... Nasdaq market closes on Wednesday, October 28, 2009. ... webcast to discuss its financial results and provide a Company ... Daylight Time (5:30 a.m. Pacific Daylight Time). , Participants can ...
... 21 National Disability Employment Awareness Month marks the ... New Mobility magazine, the cutting-edge voice of disability ... www.newmobility.com ), written and edited by staff and ... users into mainstream society, while simultaneously reflecting the vibrant ...
Cached Medicine Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results 2Award-Winning Disability Lifestyle Magazine Celebrates 20 Years of Publication - And 20 Years of Employing People with Disabilities 2
(Date:9/19/2014)... in infertile land, and bear many beans that are ... most legumes have a symbiotic relationship with bacteria, called ... then supply the host plant with ammonia as a ... nodules in their roots. However, if too many root ... of the plants, because the energy cost of maintaining ...
(Date:9/19/2014)... Lifeinsuranceprices.info has released a new blog post announcing ... online. , Clients who smoke or use other ... quotes from multiple providers on a single website. Insurance ... Smoking will always influence life insurance prices, in a ... for life coverage and if they have health issues, ...
(Date:9/19/2014)... PA (PRWEB) September 19, 2014 InventHelp, ... its clients, an inventor from New York, has created an ... patient from inclement weather or smoke during transport. This ... snapped to a stretcher and remain in place until removed, ... for a more comfortable move with protection from irritating smoke ...
(Date:9/19/2014)... 19, 2014 Outsourcing services provider Profit By ... US IT conglomerate to provide HR outsourcing services in India. ... an exclusive partner and will act as a talent acquisition ... deploy over 120 personnel across 3 locations in India in ... , "This is a significant win for us and we ...
(Date:9/19/2014)... FL (PRWEB) September 19, 2014 Dr. ... introduced Therapeutic Periodontal Treatment to their Miami practice. ... Dr. Gallardo and Dr. Lamas are one of ... the ‘total health’ approach for diagnosing and treating periodontal ... of the most under-diagnosed and under-treated diseases in the ...
Breaking Medicine News(10 mins):Health News:Long-distance communication from leaves to roots 2Health News:Smokers Can Compare Term Life Insurance Quotes At Lifeinsuranceprices.info! 2Health News:InventHelp® Client Patents “Patient Protector” – Designed to Protect Patients During Transport 2Health News:Profit By RPO Bags huge RPO contract from US-based Implementation Partner 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 3
... study conducted by the researchers at New York University School ... Asian immigrants are carriers// of the hepatitis B virus. These ... But it is surprising to know that most of the ... people who are infected had no health insurance. The rate ...
... place on record the exemplary work of art by students from ... by Oman in the ‘Unite for children Unite against Aids’ campaign ... for Children Unite Against Aids’ campaign encompasses four major goals spread ... percentage of the young victims of HIV/Aids; to provide better services ...
... Health workers by the Ontario government, to beat a possible ... from critics // , who see this is politically motivated ... The opinion doing the rounds is that the kits ... ,According to health minister George Smitherman, 15,000 emergency kits will ...
... Exercising for at least for half an hour a day and ... serving of vegetables and fish, may be the key// to longevity ... Health Organization. ,According to the study, exercising just 30 ... cycling and even climbing the stairs are included in the tally, ...
... University have developed ,the first knee replacement shaped to ... the U.S. Food and Drug Administration, and will be ... ,Dr. Aaron G. Rosenberg and Dr. Richard A. Berger, ... who sought to address shape-related differences of a woman’s ...
... A systematic review of studies has revealed that surgery ... intrauterine medication for women experiencing heavy periods in reducing ... ,However, on subjective measures of effectiveness — satisfaction and ... (IUD) is as effective as surgery, the review found. ...
Cached Medicine News:Health News:East Asian Immigrants Bring Hepatitis to New York 2Health News:Shapelier Knee Replacements for Women 2Health News:Shapelier Knee Replacements for Women 3Health News:Shapelier Knee Replacements for Women 4Health News:Surgery or IUD for Heavy Periods 2Health News:Surgery or IUD for Heavy Periods 3
Fine abrasive for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Standard knife with box, C profile...
... is a refrigerated design for use as a ... with the 8000 sledge microtome, however, it can ... stage gives a large working area of 130 ... provide good adhesion between the specimen and the ...
Medicine Products: